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Left ventricular ejection fraction (EF) depends on ventric-
ular contractility, afterload, and preload. Preload is related
to end-diastolic volume (EDV) and pressure; the relation-
ship between these 2 parameters (the end-diastolic pressure-
volume relationship, EDPVR) indexes the degree of
ventricular remodeling. Although EF is known to correlate
with mortality in the subset of heart failure patients with
reduced EF, it is previously unknown which of its deter-
mining factors contribute most importantly to prognosis. In
this issue of the Journal, Ky et al. (1) set out to address this
fundamental question using pressure-volume (PV) analysis,
the most powerful approach for addressing such a problem.See page 1165They conclude that the extent of ventricular remodeling
(indexed by a number of different parameters) and the
degree of ventricular-arterial mismatching indexed by the
ratio of end-systolic elastance (Ees, an index of ventricular
contractility [2,3]), to effective arterial elastance (Ea, an
index of afterload [4]), are the most important determinants
of prognosis. They also showed that Ees by itself was not
prognostic, the implication being that ventricular chamber
contractility is not a determinant of prognosis. The methods,
ﬁndings, and interpretations described in this study deserve
further consideration.
The utility of PV loops and PV relationships to charac-
terize and quantify the mechanical properties of the left
ventricle was demonstrated by Otto Frank in 1895 (5). After
signiﬁcant research in the early part of the 20th century
culminating in the development of the time-varying ela-
stance theory of ventricular contraction by Suga (6,7) and
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gists considered PV analysis to be the gold standard for
assessing ventricular properties by the early 1980s (8). Yet,
this approach has yet to become the gold standard in clinical
practice or in clinical research. This is mainly because the
invasive techniques generally required for measurement of
pressure and volume render them impractical on a routine
basis. However, with recent technological and conceptual
advances that allow noninvasive estimation of these rela-
tionships (9–11), this situation is changing. Originally
validated (9–11) and used (12–14) in studies involving small
numbers of patients, reports have started appearing in which
these noninvasive approaches are being used in relatively
large numbers of patients (15,16).
Ky et al. (1) report results from 466 patients using
noninvasive PV analysis. One major advantage of the PV
approach is revealed when the average results of this study
are presented graphically and preload, afterload, contractility
and remodeling can be viewed so that the physiological
meaning of changes in these parameters can be readily and
simultaneously appreciated. Using the data from Table 2 of
Ky et al. (1) (with a few reasonable assumptions), it is
possible to plot average estimated PV loops and estimated
end-systolic pressure-volume relationships (ESPVRs).
Results for patients with New York Heart Association
(NYHA) functional class I symptoms are shown in
Figure 1A. In patients with progressively worse clinical heart
failure (NYHA functional class II [Fig. 1B]; NYHA func-
tional class III, [Fig. 1C]; NYHA functional class IV
[Fig. 1D]), the loops shift progressively to the right toward
larger volumes; a sign of progressive remodeling.
Concomitantly, the width of the loop decreases (i.e.,
decreased stroke volume) and the height of the loop
decreases (i.e., decreased pressure generation). There is
a relatively subtle increase in afterload as indexed by the Ea,
the index of afterload (4). Regarding the estimated ESPVR,
the main change is a progressive rightward shift toward
larger volumes (again, a manifestation of progressive re-
modeling) with a statistically nonsigniﬁcant decrease in the
slope, estimated by the “single beat method” (Eessb) (9). To
the best of my knowledge, this is the ﬁrst time that these
fundamental relationships between symptom severity and all
aspects of progressive remodeling and ventricular-arterial
mismatching has been demonstrated so clearly.
In general, a thorough assessment of remodeling should
involve estimation of the end-diastolic pressure-volume
relationship (EDPVR). This is also possible noninvasively
if an estimate of ventricular end-diastolic pressure is ava-
ilable (10,11) (not available in the present study). Evalua-
tion of the EDPVR is required to ensure that shifts of
the EDV are not simply related to changes in ﬁlling pre-
ssure, but reﬂect true changes in heart structure. Never-
theless, with changes in volumes as large as those reported
by Ky et al. (1), it is assured that the results reﬂect pro-
gressive remodeling, especially in the NYHA functional
class III and IV patients.
Figure 1 Estimated Pressure-Volume Loops and Relationships
Data from New York Heart Association functional class I patients (A) are compared with those of functional class II (B), functional class III (C), and functional class IV (D). Figure
made from data from Ky et al. (1). Ea ¼ arterial elastance; Eessb ¼ end-systolic elastance derived from single beat method; Vo,sb ¼ ESPVR volume axis intercept derived from
single beat method.
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volume [SV] to EDV; EF ¼ SV/EDV) seen by Ky et al.
(1) with worsening NYHA functional class is readily
appreciated from the graphs to be mainly due to the increase
in EDV (remodeling) and, to a lesser extent, a reduction in
SV. The reduction in SV, in turn, is mainly due to an
increase in Ea (the major determinant of which is total
peripheral resistance) with no signiﬁcant change in Eessb.
Ky et al. (1) further show that in patients with reduced
EF heart failure, the composite of all-cause mortality, heart
transplantation, and left ventricular assist device implanta-
tion is most strongly associated with the degree of ven-
tricular remodeling, as indexed by any parameter related to
the size of the heart, including EDV, volume at an end-
systolic pressure of 100 mm Hg (V100) and the volume axis
intercept of the ESPVR (V0). Not surprisingly, because EF
is mainly determined by EDV, outcomes also correlated very
strongly with EF, as shown in previous studies. A totally
new ﬁnding is that outcomes are also determined by
abnormally high Ea and even more so by abnormal
ventricular-vascular coupling indexed by the Ea/Eessb ratio.
This is explained by the fact that as heart failure worsens,
afterload (Ea) increases and the ESPVR slope (Eessb) tends
to decrease; taking the ratio of these 2 parameters therefore
ampliﬁes the impact of either alone.Although Ees, the slope of the presumed linear ESPVR,
is considered to be the most reliable index of ventricular
contractility, the implications of deviations from ideal
behavior need to be considered (17). Speciﬁcally, when
extreme changes in contractility and extreme degrees of
remodeling are involved, as are present in the current study
of patients with severe (NYHA functional classes III and
IV) heart failure (Fig. 2), several factors must be considered
when interpreting Ees as an index of contractility. First, with
signiﬁcant remodeling, true V0 (the ESPVR volume axis
intercept) may increase. Second, the ESPVR can become
nonlinear (18,19). To evaluate for this, PV data must be
obtained over a fairly wide range of pressures, which is not
usually possible in patients. This is illustrated by data from
ex vivo blood perfused, beating human hearts obtained at the
time of transplantation (Fig. 2A) (19). The curvilinear
nature of the ESPVR seen in the largest, most remodeled
hearts is readily apparent; the slope of a straight line drawn
through the data cannot, by itself, capture the changes in the
relationship. In addition, the ESPVR can become nonlinear
in normal hearts operating at signiﬁcantly reduced or
signiﬁcantly increased levels of contractility (Fig. 2B) (18).
Thus, although the ESPVR may be well approximated by
a straight line over a limited working range of pressures and
volumes, in such cases, extrapolation to the low pressure
Figure 2 Implications of Nonlinear ESPVR
(A) Data from ex vivo blood perfused human hearts obtained at the time of heart
transplantation showing nonlinear end-systolic pressure-volume relationship
(ESPVR) in extremely remodeled hearts (19). (B) Data from normal ex vivo
cross-perfused canine hearts showing nonlinear ESPVRs with extreme acute
increases and decreases in contractility achieved by drug infusion. (C) Demon-
stration that linear approximation of the ESPVR from data over a limited operating
pressure-volume range (red) will not reﬂect the true ESPVR or Vo (systolic pressure
of 0 mm Hg) (blue). Thus, when dealing with a potentially nonlinear ESPVR,
changes in linearized Ees and extrapolated Vo must both be accounted for in
assessment of chamber contractility (17).
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1175range is not likely to be accurate (Fig. 2C). Therefore, it
must be recognized that when the ESPVR is assessed over
a limited PV range or when a single beat method is used, the
low pressure range of the extrapolated ESPVR may not
reﬂect reality. Therefore, it is important to consider shifts of
the extrapolated ESPVR in the assessment of changes in
contractility, which requires that changes in the extrapolated
V0 be accounted for.
One approach for combining information about local Ees
and extrapolated V0 is to calculate the volume at a given
pressure on the ESPVR (17). For example, Ky et al. (1)
calculated end-systolic volume at an end-systolic pressure
of 100 mmHg (i.e., V100¼ 100/Ees þ V0); in this case V100
may be considered a contractility index surrogate (the larger
the V100, the lower the contractility). Although this is
imperfect, it does offer a practical solution to the problem.
The implication for interpretation of the results of Ky et al.
is that, although Eessb did not change signiﬁcantly with
progressive worsening of heart failure, reductions in chamber
contractility are clearly illustrated by the rightward shifts of the
ESPVR as captured by changes in V100. If this premise is
accepted, it should therefore be concluded from the data (1)
that ventricular chamber contractility is indeed a strong
statistical determinant of prognosis in reduced EF heart failure.
It is also important to note that the current study used a
single-beat approach to estimating Ees. The more traditional
approach requires measurement of pressures and volumes
over a signiﬁcant change in load, most typically achieved by
preload reduction via inferior vena caval occlusion. However,
that approach can only be used with invasive methods, which
renders it impractical for large-scale clinical studies. Although
the single-beat method has been validated (9) and has
opened important opportunities for noninvasive application
of PV analysis, potential inaccuracies may exist. It is also
noteworthy that invasive techniques for measuring PV loops
and relationships are becoming easier to perform and analyze
as newer devices and software become available (many recent
references have appeared; see as just one example [20]).
In summary, noninvasive PV analysis is feasible in large-
scale studies, provides clinically meaningful results, and has
the potential to provide more information than measures of
volumes alone. PV analysis as used by Ky et al. (1) in
a population of reduced EF heart failure shows the following
new and important ﬁndings:
 With worsening degrees of heart failure symptoms,
there are greater degrees of remodeling.
 The more remodeling that has occurred, the worse the
prognosis.
 The greater the mismatch is between ventricular and
vascular properties, the worse the prognosis.
 The data emphasize the point that Ees (or Eessb)
should be considered the slope of the ESPVR in
the working PV range of the heart. Full assessment
of changes in contractility requires accounting for
changes in both Ees and extrapolated V0, especially at
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that have undergone extreme degrees of remodeling.
 Accepting that V100 is an index of ventricular chamber
contractility, the data also show that ventricular con-
tractility is an important determinant of prognosis.
Although we tend to think of remodeling and changes in
contractility as different aspects of ventricular properties, if
one digs just a little deeper into the points listed above, one
arrives at the understanding that, in practical terms, for
patients with reduced EF heart failure, a remodeled heart is
intrinsically a heart with reduced contractility. Remodeling
and reduction in chamber contractility are intimately linked
and, in the end, inseparable phenomena.
Reprint requests and correspondence: Dr. Daniel Burkhoff,
Division of Cardiology, Columbia University, 177 Fort Washington
Avenue, New York, New York 10032. E-mail: db59@colubmia.edu.
REFERENCES
1. Ky B, French B, Khan AM, et al. Ventricular-arterial coupling, remod-
eling, and prognosis in chronic heart failure. J AmColl Cardiol 2013;62:
1165–72.
2. Suga H, Sagawa K, Kostiuk DP. Controls of ventricular contractility
assessed by pressure-volume ratio, Emax. Cardiovasc Res 1976;10:582–92.
3. Sagawa K, Suga H, Shoukas AA, Bakalar KM. End-systolic pressure-
volume ratio: a new index of ventricular contractility. Am J Cardiol
1977;40:748–53.
4. Sunagawa K, Maughan WL, Burkhoff D, Sagawa K. Left ventricular
interaction with arterial load studied in isolated canine ventricle. Am J
Physiol 1983;245:H773–80.
5. Frank O. Zur Dynamik des Herzmuskels. Z Biol 1895;32:370–447.
6. Suga H. Time course of left ventricular pressure-volume relationship
under various extents of aortic occlusion. Jpn Heart J 1970;11:373–8.
7. Suga H. Time course of left ventricular pressure-volume relationship
under various end diastolic volume. Jpn Heart J 1969;10:509–15.
8. Sagawa K. Editorial: The end-systolic pressure-volume relation of the
ventricle: deﬁnition, modiﬁcations and clinical use. Circulation 1981;
63:1223–7.9. Chen CH, Fetics B, Nevo E, et al. Noninvasive single-beat determi-
nation of left ventricular end-systolic elastance in humans. J Am Coll
Cardiol 2001;38:2028–34.
10. Klotz S, Hay I, Dickstein ML, et al. Single-beat estimation of end-
diastolic pressure-volume relationship: a novel method with potential
for noninvasive application. Am J Physiol Heart Circ Physiol 2006;291:
H403–12.
11. Klotz S, Dickstein ML, Burkhoff D. A computational method of
prediction of the end-diastolic pressure-volume relationship by single
beat. Nat Protoc 2007;2:2152–8.
12. Maurer MS, Sackner-Bernstein JD, Rumbarger LE, Yushak M,
King DL, Burkhoff D. Mechanisms underlying improvements in
ejection fraction with carvedilol in heart failure. Circ Heart Fail 2009;2:
189–96.
13. He KL, Burkhoff D, Leng WX, et al. Comparison of ventricular
structure and function in Chinese patients with heart failure and
ejection fractions >55% versus 40% to 55% versus<40%. Am J Cardiol
2009;103:845–51.
14. Bhuiyan T, Helmke S, Patel AR, et al. Pressure-volume rela-
tionships in patients with transthyretin (ATTR) cardiac amyloi-
dosis secondary to V122I mutations and wild-type transthyretin:
Transthyretin Cardiac Amyloid Study (TRACS). Circ Heart Fail
2011;4:121–8.
15. Lam CS, Roger VL, Rodeheffer RJ, et al. Cardiac structure and
ventricular-vascular function in persons with heart failure and preserved
ejection fraction from Olmsted County, Minnesota. Circulation 2007;
115:1982–90.
16. Spevack DM, Karl J, Yedlapati N, Goldberg Y, Garcia MJ.
Echocardiographic left ventricular end-diastolic pressure volume loop
estimate predicts survival in congestive heart failure. J Card Fail 2013;
19:251–9.
17. Burkhoff D, Mirsky I, Suga H. Assessment of systolic and diastolic
ventricular properties via pressure-volume analysis: a guide for clinical,
translational, and basic researchers. Am J Physiol Heart Circ Physiol
2005;289:H501–12.
18. Burkhoff D, Sugiura S, Yue DT, Sagawa K. Contractility-dependent
curvilinearity of end-systolic pressure- volume relations. Am J Physiol
1987;252:H1218–27.
19. Burkhoff D, Flaherty JT, Yue DT, et al. In vitro studies of isolated
supported human hearts. Heart Vessels 1988;4:185–96.
20. Gaemperli O, Biaggi P, Gugelmann R, et al. Real-time left ventricular
pressure-volume loops during percutaneous mitral valve repair with the
MitraClip system. Circulation 2013;127:1018–27.Key Words: ejection fraction - heart failure - mechanics.
